drugset / Trial / NCT01593826

Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

NCT01593826 ↗

Phase 1 Completed 72 enrolled Orion Corporation, Orion Pharma
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to compare the test product Budesonide/formoterol Easyhaler with the marketed product Symbicort Turbuhaler in terms of the drug absorbed into the bloodstream.

Timeline

Start
2012-05
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide/formoterol Unknown 9 ug Inhaled
Subject Budesonide/formoterol Unknown 320 ug Inhaled

Indications